Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs10403306 | chr19:37375279 | C/T | 6.99E-7 | 178 | 25.1 | 23.82 | 25.6 | KM Plot |
PCPG | rs10416924 | chr19:19719840 | A/G | 0.000376 | 176 | 24.93 | 27.78 | 20.25 | KM Plot |
PCPG | rs10417097 | chr19:19719824 | C/G | 0.000382 | 178 | 20.25 | 28.3 | 24.7 | KM Plot |
PCPG | rs10419415 | chr19:2868842 | G/A | 0.000312 | 173 | 25.77 | 16.97 | 116.37 | KM Plot |
PCPG | rs1042712 | chr2:136545844 | C/G | 2.26E-5 | 178 | 9.72 | 24.98 | 25.77 | KM Plot |
PCPG | rs1045452 | chr12:6572048 | A/G | 0.000132 | 171 | 19.57 | 27.23 | 24.85 | KM Plot |
PCPG | rs1045548 | chr12:6570966 | C/T | 0.000237 | 178 | 25.87 | 25.47 | 19.3 | KM Plot |
PCPG | rs10459546 | chr14:74419247 | A/T | 4.78E-6 | 172 | 25 | 30.33 | 10.43 | KM Plot |
PCPG | rs10459547 | chr14:74419642 | G/T | 4.63E-6 | 173 | 25.17 | 29.7 | 10.43 | KM Plot |
PCPG | rs10459894 | chr17:74696030 | A/T | 0.000283 | 171 | 25.77 | 25.53 | 8.33 | KM Plot |
PCPG | rs1046914 | chr10:1228206 | T/C | 0.000253 | 172 | 23.48 | 25.87 | 25.17 | KM Plot |
PCPG | rs10483856 | chr14:74365295 | C/T | 9.42E-6 | 178 | 10.43 | 27.23 | 25.47 | KM Plot |
PCPG | rs10490630 | chr2:118687240 | C/T | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs10490631 | chr2:118678439 | C/T | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs10491079 | chr10:131960803 | C/T | 0 | 178 | 25.53 | 24.47 | 3.17 | KM Plot |